Suppr超能文献

熊去氧胆酸给药诱导的原发性胆汁性肝硬化患者胆汁酸组成的变化。

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

作者信息

Crosignani A, Podda M, Battezzati P M, Bertolini E, Zuin M, Watson D, Setchell K D

机构信息

Department of Internal Medicine, University of Milan, Italy.

出版信息

Hepatology. 1991 Dec;14(6):1000-7.

PMID:1959845
Abstract

We describe a detailed study of the effects of ursodeoxycholic acid administration on bile acid composition of the serum and bile of patients with primary biliary cirrhosis. Gas chromatography-mass spectrometry was used to analyze bile acids from 10 patients with primary biliary cirrhosis before and during ursodeoxycholic acid administration (500 mg/day, corresponding to approximately 8 mg/kg body wt), after group separation of the unconjugated and conjugated fractions by lipophilic anion exchange chromatography. These studies were directed at assessing whether the beneficial role of ursodeoxycholic acid in primary biliary cirrhosis was the consequence of a shift in the hydrophobic/hydrophilic balance of the bile acid pool and whether the hypercholeresis might result from the cholehepatic circulation of unconjugated ursodeoxycholic acid in bile. In basal conditions, the unconjugated bile acids accounted for only 5.5% and 2.5%, respectively, of the total bile acids of serum and bile; cholic acid was the major component of the conjugated fraction of serum and bile (56.0% +/- 4.0%, mean +/- S.E.M.), and ursodeoxycholic acid was present in only trace amounts. The conjugated fraction contained many unusual bile acids (representing 16.5% +/- 1.3% of total) including C25 bile acids, iso-chenodeoxycholic acid and several oxo-bile acids. After ursodeoxycholic acid administration biochemical indices of liver function all improved, but the proportions of the unconjugated bile acids in serum and bile did not significantly change.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们描述了一项关于熊去氧胆酸给药对原发性胆汁性肝硬化患者血清和胆汁中胆汁酸组成影响的详细研究。采用气相色谱 - 质谱联用技术,通过亲脂性阴离子交换色谱法对未结合和结合部分进行分组分离后,分析了10例原发性胆汁性肝硬化患者在服用熊去氧胆酸(500毫克/天,约相当于8毫克/千克体重)之前和期间的胆汁酸。这些研究旨在评估熊去氧胆酸在原发性胆汁性肝硬化中的有益作用是否是胆汁酸池疏水/亲水平衡改变的结果,以及胆汁中未结合熊去氧胆酸的胆肝循环是否可能导致胆汁分泌过多。在基础状态下,未结合胆汁酸分别仅占血清和胆汁总胆汁酸的5.5%和2.5%;胆酸是血清和胆汁结合部分的主要成分(56.0%±4.0%,平均值±标准误),而熊去氧胆酸仅以痕量存在。结合部分包含许多不寻常的胆汁酸(占总量的16.5%±1.3%),包括C25胆汁酸、异鹅去氧胆酸和几种氧代胆汁酸。服用熊去氧胆酸后,肝功能生化指标均有所改善,但血清和胆汁中未结合胆汁酸的比例没有显著变化。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验